Virtual Reality for Alleviation of Peripheral IV Placement-Associated Discomfort

Sponsor
Brooke Army Medical Center (U.S. Fed)
Overall Status
Recruiting
CT.gov ID
NCT03740607
Collaborator
(none)
100
1
2
42.5
2.4

Study Details

Study Description

Brief Summary

Immersive virtual reality (iVR) has been used successfully to manage pain with distraction. It is a non-invasive treatment modality unassociated with worrisome well-known side effects typically seen when opioids and NSAIDS are used, and has previously been used safely in place of analgesia during dressing changes and burn care. This study investigates whether iVR can be useful as a stand-alone option to manage the pain associated with placement of peripheral intravenous (PIV) catheters in adults.

Condition or Disease Intervention/Treatment Phase
  • Device: Virtual reality
  • Procedure: Peripheral intravenous catheter placement
N/A

Detailed Description

This is a prospective study of the effect of immersive virtual reality on the perception of pain during peripheral IV (PIV) placement. Adult patients who require PIV placement for elective surgery will be consented for intervention while in the peri-operative suites (PS). The VR intervention will consist of a headset and immersive VR software that allows the patient to engage in a virtual world during PIV placement. Subjects will be queried immediately after PIV placement using the validated graphic rating scale regarding the sensory, cognitive, and affective aspects of discomfort they experienced with PIV placement (Appendix A). They will also be asked two validated questions concerning patient satisfaction (Dexter et al 1997). A control group of patients will undergo a similar assessment with slightly different wording after receiving PIV placement without iVR.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Intervention Model Description:
randomized prospective cohortrandomized prospective cohort
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Virtual Reality for Alleviation of Peripheral IV Placement-Associated Discomfort
Actual Study Start Date :
Mar 1, 2019
Anticipated Primary Completion Date :
Sep 1, 2022
Anticipated Study Completion Date :
Sep 15, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Virtual reality during PIV placement

Randomized consented adult subjects will participate in a six-minute healthcare virtual reality software program via Samsung Gear virtual reality headsets while receiving 18 or 20-gauge peripheral intravenous catheter placement in peri-operative suite in preparation for surgery. They will be asked to rate their pain and discomfort afterwards using a graphic rating scale. They will be asked several questions about satisfaction, in order to elicit clinical significance of this intervention. Demographic information will be collected, and baseline vital signs upon arrival to OR will be abstracted retrospectively.

Device: Virtual reality
Healthcare virtual reality software implemented during peripheral intravenous catheter placement
Other Names:
  • Samsung Gear Headset, AppliedVR software
  • Procedure: Peripheral intravenous catheter placement
    Peripheral intravenous catheters are placed in the peri-operative suites in preparation for anesthesia during surgery.
    Other Names:
  • IV
  • PIV
  • Placebo Comparator: Standard PIV placement

    Adult control arm subjects will receive 18 or 20-gauge peripheral intravenous catheter placement according to current standard protocol, without virtual reality distraction .They will be asked to rate pain and discomfort afterwards using a graphic rating scale. Demographic information will be collected, and baseline vital signs upon arrival to OR will be abstracted retrospectively.

    Procedure: Peripheral intravenous catheter placement
    Peripheral intravenous catheters are placed in the peri-operative suites in preparation for anesthesia during surgery.
    Other Names:
  • IV
  • PIV
  • Outcome Measures

    Primary Outcome Measures

    1. Discomfort associated with peripheral IV placement [This outcome will be measured immediately after peripheral IV placement]

      Subject experiences will be measured using a validated graphic rating scale (GRS) which enquires about the extent to which the experience was unpleasant.

    Secondary Outcome Measures

    1. Magnitude of pain severity [This outcome will be measured immediately after peripheral IV placement]

      Subjects will rate their worst pain during the IV placement on a scale of 1-10 out of 10 possible points

    2. Time spent thinking about pain [This outcome will be measured immediately after peripheral IV placement]

      Subject will describe the amount of time spent thinking about pain during IV placement, as a proportion.

    3. Degree to which subject felt immersed in virtual reality [This outcome will be measured immediately after peripheral IV placement]

      The subject will answer a question regarding the extent to which they felt they went "inside" the computer-generated world

    4. Nausea [This outcome will be measured immediately after peripheral IV placement]

      Subject will answer a question regarding extent to which nausea was experienced during IV placement

    5. Claustrophobia [This outcome will be measured immediately after peripheral IV placement]

      The subject will be asked to answer a question about the extent to which they felt claustrophobic for any reason during IV placement

    6. Clinical significance [This outcome will be measured immediately after peripheral IV placement]

      the subject will be asked if they would want to have their IV placed this way again

    7. Satisfaction score [This outcome will be measured immediately after peripheral IV placement]

      The subject will be asked if they were satisfied with IV placement

    8. Physiological parameters [Initial vital signs at start of anesthesia care will be abstracted retrospectively. This reading will likely occur within an hour of the initial intervention, as start times for anesthesia cases are within an hour of initiation of peri-operative care]

      Baseline vital signs- continuous variables

    9. Fun factor [This outcome will be measured immediately after peripheral IV placement]

      Subject will describe the extent to which they found the experience to be fun, on a scale of 1-10

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 89 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    Brooke Army Medical Center patients age 19-89 undergoing peripheral intravenous catheter placement in preparation for elective surgery will be eligible for participation.

    Exclusion Criteria:

    Patients will be excluded with head wounds/head bandages preventing the use of a headset, active nausea/vomiting, history of seizure, dementia, psychosis, mania, vertigo, or motion sickness, if the patient is pregnant or incarcerated on the day of surgery, and if the patient is unable to consent self.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Brooke Army Medical Center San Antonio Texas United States 78234

    Sponsors and Collaborators

    • Brooke Army Medical Center

    Investigators

    • Study Director: Christopher Maani, MD, BAMC Faculty

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Annie Chow, Principal Investigator, Brooke Army Medical Center
    ClinicalTrials.gov Identifier:
    NCT03740607
    Other Study ID Numbers:
    • c.2017.114d
    First Posted:
    Nov 14, 2018
    Last Update Posted:
    Aug 26, 2021
    Last Verified:
    Aug 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    Yes
    Keywords provided by Annie Chow, Principal Investigator, Brooke Army Medical Center
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 26, 2021